Security
BSEM · BioStem Technologies, Inc.
BSEMOTCCommon stockHistorical · closed Aug 6, 2026CIK 1658678Updated Sep 26, 2026
BSEM price & chart
This listing closed Aug 6, 2026. Live provider charts are shown only for current listings.
Current security: BSEM
In the news
No coverage from other publishers is available.
Recent filings
Offerings
Registration 333-299025
Registration 333-297780
Filing attachments
bsem-ex99_1.htm · 8-K · 2026-09-18
EX-99.1 4 bsem-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility POMPANO BEACH, Fla., Sept. 18, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced it has entered into a $40 million Committed Equity Facility (the “CEF”)…
Read attachment ↗bsem-ex99_1.htm · 8-K · 2026-08-12
EX-99.1 2 bsem-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 BioStem Technologies Reports Second Quarter 2026 Financial Results Generates 29% sequential revenue growth, increasing to $7.9 million; Raises full-year 2026 revenue guidance Uplists to Nasdaq Capital Market POMPANO BEACH, FL, August 12, 2026 (GLOBE NEWSWIRE) - BioStem Technologies, Inc. (Nasdaq: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allog…
Read attachment ↗bsem-ex99_1.htm · 8-K · 2026-08-07
EX-99.1 2 bsem-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 BioStem Technologies Announces Nasdaq Uplisting Trading to Commence on August 7, 2026 POMPANO BEACH, Fla., August 6, 2026 - BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that The Nasdaq Stock Market LLC (“Nasdaq”) has completed its review of the Company’…
Read attachment ↗